Physician profile
Frederick A Pich
NPI 1962608455
$382.77
in general payments reported to CMS, 2019-2025
10 companies · $54.82 in 2025
The $54.82 reported for 2025 was less than what a typical Emergency Medicine provider received nationally (typical 2025 total: $57.10).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $41.64 · 2020: $109 · 2021: $91.04 · 2022: $45.30 · 2023: $41.17 · 2025: $54.82.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $95.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $95.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $65.21 | 2020-2022 | |
| Abbvie INC. | $58.29 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $55.17 | 2020-2021 | |
| E.R. Squibb & Sons, L.L.C. | $43.52 | 2020-2025 | Eliquis |
| Allergan, INC. | $41.97 | 2019-2020 | |
| Purdue Pharma L.P. | $37.54 | 2025 | Nalmefene Hydrochloride |
| Grifols USA, LLC | $26.44 | 2019-2020 | |
| Melinta Therapeutics, LLC | $21.79 | 2023 | Kimyrsa |
| Inari Medical, INC. | $19.38 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Genentech USA, INC. | $13.46 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Frederick Pich listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.